R. K. Verbeeck, “The Lidose Hard Capsule Formulation of Fenofibrate is Suprabioavailable Compared to the Nanoparticle Tablet Formulation Under High-fat Fed Conditions”, J Pharm Pharm Sci, vol. 18, no. 1, pp. 61–67, Feb. 2015.